Genix Pharmaceuticals Ratios and Metrics

Market cap in millions CAD. Fiscal year is November - October.

Millions CAD. Fiscal year is Nov - Oct.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 5, 2026	Oct '24 Oct 31, 2024	Oct '23 Oct 31, 2023	Oct '22 Oct 31, 2022	Oct '21 Oct 31, 2021	Oct '20 Oct 31, 2020
Market Capitalization	1	3	2	4	9	10
Market Cap Growth	-87.84%	25.00%	-38.46%	-56.67%	-9.37%	273.29%
Enterprise Value	2	4	3	4	9	9
Last Close Price	0.02	0.05	0.04	0.07	0.15	0.17
PS Ratio	18007.10	730.98	191.87	-	-	-
PB Ratio	-0.86	-2.50	-2.08	1.20	2.21	2.02
P/TBV Ratio	-	-	-	-	-	43.40
EV/Sales Ratio	-	910.96	225.59	-	-	-
EV/EBITDA Ratio	10.83	20.25	-	-	-	-
Debt / Equity Ratio	-0.72	-0.69	-0.45	0.06	0.01	0.00
Debt / EBITDA Ratio	4.94	4.48	-	-	-	-
Asset Turnover	0.00	0.03	0.01	-	-	-
Inventory Turnover	-	-	0.06	-	-	-
Quick Ratio	0.00	0.01	0.01	0.02	0.19	2.01
Current Ratio	0.02	0.03	0.16	0.23	0.25	2.05
Return on Equity (ROE)	-	-	-426.41%	-29.78%	-37.25%	-29.85%
Return on Assets (ROA)	-163.17%	-169.16%	-23.23%	-13.83%	-19.90%	-15.75%
Return on Capital Employed (ROCE)	23.80%	30.80%	73.10%	-31.20%	-40.00%	-13.60%
Earnings Yield	-7.25%	-2.47%	-185.55%	-27.90%	-18.60%	-7.33%
FCF Yield	-	-6.33%	-9.31%	-5.70%	-4.82%	-1.99%
Buyback Yield / Dilution	-	-	-	-	-18.55%	-33.17%

Updated Jul 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.